Dr Stock Pick HOT News & Alerts!

_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________

Saturday Nov 28, 2009

DrStockPick.com Stock Report!

**************************************************************

PGCX, PanGenex Corporation, PGCX.PK

PGCX pursues business opportunities in the $70 billion dollar nutraceutical and dietary supplement industry. With a focus specifically on the cardiovascular health segment, PGCX develops and markets sector leading, patented or patent pending, condition specific nutraceuticals and topical over-the-counter (OTC) drugs and personal care products. Each product is scientifically formulated to address specific health conditions throughout the population.

PGCX has a strategic partnership (which it supports the joint development and commercialization of PGCX’s nutraceutical and healthcare products) with BulovaTech Labs, Inc., a wholly-owned subsidiary of Bulova Technologies Group Inc. that will accelerate the development of proprietary technologies and products, which will be marketed by PGCX under the PanGenex trademark.

Clinical trial involving a protocol to test its product Calci-CLEAR, a two part system designed to cleanse and remove calcium deposits from soft tissues such as veins and arteries (an important and pervasive condition affecting hundreds of millions of people worldwide), showed promising pre-clinical results.

PGCX anticipated the release of its long form television program, demonstrating the benefits of Calci-CLEAR™, its patent pending dietary supplement that addresses soft tissue calcification, pursuant to its partnership with Incredible Discoveries® in early 2010.

Incredible Discoveries®, a wholly-owned subsidiary of O2Media Inc., is a fully integrated production, marketing and investment partnership company that introduces new products to consumers through infomercial development and multi-channel marketing opportunities, including international retail distribution, the highest rated live shopping networks, direct mail catalogs, and insert programs.

This program will allow PGCX and its physician partners to reach a broad and diverse audience, an audience where an estimated 1 of every 5 adults has complications associated with soft tissue calcification, Opening the Door for PGCX to a Multi-billion Dollar Nutraceutical and Dietary Supplement Industry.

Take a look at PGCX 5 days chart

More about PGCX at www.pangenex.com

PGCX, X-Treme Hot Stock Alert by DrStockPick.com

***********Advertisement***********

******************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Disclaimer: Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. (read more) . Rule 17B requires disclosure of payment for investor relations.